China Prostate Cancer Diagnostic and Therapeutic Market Size, Share & Trends Analysis Report and Forecast 2019-2025


Posted March 7, 2022 by Nim0196

China is the most populated country and an emerging economy. China prostate cancer market is forecast to grow at a CAGR of around 8.5% during the forecast period.

 
Get Free Sample link @ https://www.omrglobal.com/request-sample/china-prostate-cancer-diagnostic-therapeutic-market
China prostate cancer diagnostic and therapeutics market is segmented on the basis of diagnostic techniques and therapeutics. By diagnostic technique the market is further is segmented into prostate-specific antigen test, digital rectal examination, prostate biopsy, imaging techniques. Imaging techniques segment is expected to have a significant growth rate in the country during the forecast period. By therapeutics, the market is further divided into hormonal therapy, chemotherapy, immunotherapy, radiation therapy, targeted therapy, surgery. Radiation therapy is the main treatment for localized prostate cancer, and a comprehensive therapy based on androgen deprivation therapy is the treatment for advanced disease.
A full report of China Prostate Cancer Diagnostic and Therapeutic Market available @ https://www.omrglobal.com/industry-reports/china-prostate-cancer-diagnostic-therapeutic-market
• Market Coverage
• Market number available for – 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Source, By Product Type, By Applications
• Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
China Prostate Cancer Market by Diagnostic Techniques
o Prostate-Specific Antigen Test (PSA)
o Digital Rectal Examination
o Prostate Biopsy
o Imaging Techniques
China Prostate Cancer Market by Therapeutics
o Hormonal Therapy
o Chemotherapy
o Immunotherapy
o Radiation Therapy
o Targeted Therapy
o Surgery
Company Profiles
o Abbott Laboratories
o AbbVie Products, LLC
o Amgen Inc.
o AstraZeneca PLC
o Bayer AG
o Bristol-Myers Squibb Co.
o Ferring Pharmaceuticals Inc.
o GlaxoSmithKline PLC
o Johnson & Johnson
o Pfizer Inc.
o Siemens Healthcare AG
o The Xian Janssen Pharmaceutical Ltd.
The Report Covers
• Comprehensive research methodology of China Prostate Cancer Market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting China Prostate Cancer Market.
• Insights about market determinants which are stimulating China Prostate Cancer Market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/china-prostate-cancer-diagnostic-therapeutic-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Anurag Tiwari
Country India
Categories Business
Tags china prostate cancer diagnostic and therapeutic
Last Updated March 7, 2022